Bupivacaine Pain Pumps to Decrease Mastectomy Post-Operative Pain
Withdrawn before enrolling · Phase 4 · Has a placebo group
Conditions studied: Pain
In brief
This double-blind, randomized, controlled clinical trial comparing patient-reported pain and pain medication/narcotic use between patients randomized to treatment (bupivacaine) or placebo (saline) delivered via pain pump to the mastectomy site. Candidates will have chosen to have a mastectomy on one side immediately followed with tissue expander placement breast reconstruction. Patients will be randomized 1:1 to bupivacaine- (treatment) or saline-(placebo) filled percutaneously-placed pain pumps; neither the participants nor the study staff will know participants' treatment. Data on patient-perceived pain and pain medication use will be collected before surgery, during surgery, and after surgery on Days 1, 2, 3, 7, and 90, and at Years 2 and 4 by phone. The investigators hypothesize that patients randomized to the treatment (bupivacaine) group will have significantly lower pain scores and use less pain medicine than patients who receive placebo during the first 90 days following their surgery. The Year 2 and Year 4 follow-ups are included as tertiary endpoints to capture differences in chronic pain, and patients will be asked to complete the same questionnaires as at the Day 90 follow up.
Key facts
- Study ID
- NCT01494259
- Run by
- Johns Hopkins University
- People needed
- 0
- Starts
- 2016-01-01
- Expected to finish
- 2017-09-01
- Last updated by the study team
- 2015-10-14
Who can join
Age: 18 and older, up to 100. Sex: female. Healthy volunteers: not accepted.
You may qualify if…
- Be Female aged 18-100 years.
- Choose unilateral mastectomy followed by immediate tissue expander breast reconstruction.
- Have no inflammatory breast cancers.
- Be aware of the nature of her malignancy.
- Understand the study purpose, requirements, and risks.
- Be able and willing to give informed consent.
You may not qualify if…
- Any concurrent narcotic analgesic use (baseline narcotic use must be 0 to be eligible).
- Axillary lymph node dissection related to qualifying mastectomy.
Where it is running
- Dept. of Plastic and Reconstructive Surgery, Johns Hopkins — Baltimore, Maryland, United States
Full record on ClinicalTrials.gov
Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.